# A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes

> **NCT07305805** · PHASE1 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 36 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** NNC0363-1063

## Key facts

- **NCT ID:** NCT07305805
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2026-05-17
- **Final completion:** 2026-05-21
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07305805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07305805, "A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07305805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*